Association between education level and disability progression in patients with multiple sclerosis in France

被引:0
|
作者
Lefort, Mathilde [1 ]
Dejardin, Olivier [2 ]
Berger, Eric [3 ]
Camdessanche, Jean-Philippe [4 ]
Ciron, Jonathan [5 ,6 ]
Clavelou, Pierre [7 ,8 ]
De Seze, Jerome [9 ,10 ]
Debouverie, Marc [11 ,12 ]
Heinzlef, Olivier [13 ]
Labauge, Pierre [14 ,15 ]
Laplaud, David Axel [16 ]
Le Page, Emmanuelle [17 ]
Lebrun-Frenay, Christine [18 ]
Moreau, Thibault [19 ]
Pelletier, Jean [20 ]
Ruet, Aurelie [21 ,22 ,23 ]
Thouvenot, Eric [24 ,25 ]
Vukusic, Sandra [26 ,27 ,28 ,29 ,30 ]
Zephir, Helene [31 ]
Defer, Gilles [32 ]
Leray, Emmanuelle [1 ]
机构
[1] Univ Rennes, RSMS Rech Serv & Management Sante U 1309, EHESP, CNRS,Inserm,Arenes UMR 6051, Rennes, France
[2] Normandie Univ, UNICAEN, CHU Caen, INSERM U1086,ANTICIPE, Caen, France
[3] CHU Besancon, Serv Neurol, Besancon, France
[4] CHU St Etienne, Hop Nord, Dept Neurol, St Etienne, France
[5] CHU Toulouse, Dept Neurol, CRC SEP, Toulouse, France
[6] Univ Toulouse III, Infin, INSERM, CNRS,UMR5051, Toulouse, France
[7] CHU Clermont Ferrand, Dept Neurol, Clermont Ferrand, France
[8] Univ Clermont Auvergne, INSERM, Neurodol, Clermont Ferrand, France
[9] CHU Strasbourg, Dept Neurol, Strasbourg, France
[10] CHU Strasbourg, Clin Invest Ctr, CIC 1434, INSERM 1434, Strasbourg, France
[11] Nancy Univ Hosp, Dept Neurol, Nancy, France
[12] Univ Lorraine, APEMAC, Nancy, France
[13] Hop Poissy, Dept Neurol, Poissy, France
[14] CHU Montpellier, MS Unit, Montpellier, France
[15] Univ Montpellier MUSE, Montpellier, France
[16] Nantes Univ, Ctr Res Transplantat & Translat Immunol, Serv Neurol, CHU Nantes,INSERM,UMR 1064,CIC INSERM 1413, Nantes, France
[17] CHU Pontchaillou, INSERM CIC1414, Rennes, France
[18] Univ Nice Cote Azur, Ctr Hosp Univ Pasteur 2, Neurol, UR2CA,URRIS, Nice, France
[19] CHU Dijon, Dept Neurol, EA4184, Dijon, France
[20] Aix Marseille Univ, Hop Timone, APHM, Pole Neurosci Clin,Serv Neurol, Marseille, France
[21] Univ Bordeaux, Bordeaux, France
[22] INSERM, Neuroctr Magendie, U1215, Bordeaux, France
[23] CHU Bordeaux, Dept Neurol, CIC Bordeaux, CIC401, Bordeaux, France
[24] Nimes Univ Hosp, Dept Neurol, Nimes, France
[25] Univ Montpellier, Inst Genom Fonct, UMR5203, INSERM 1191, Montpellier, France
[26] Hosp Civils Lyon, Serv Neurol, Sclerose Plaques Pathol Myeline & Neuroinflammat, Bron, France
[27] Ctr Rech Neurosci Lyon, Observ Francais Sclerose Plaques, INSERM 1028, Lyon, France
[28] CNRS, UMR 5292, Lyon, France
[29] Univ Lyon, Univ Claude Bernard Lyon 1, Lyon, France
[30] Eugene Devic EDMUS Fdn Multiple Sclerosis, Bron, France
[31] Univ Lille, CHU Lille, CRCSEP Lille, U1172, Lille, France
[32] Normandie Univ, MS Expert Ctr, Dept Neurol, UNICAEN, Caen, France
关键词
Multiple sclerosis; social inequities; observational study; disability progression; DIAGNOSTIC-CRITERIA;
D O I
10.1177/13524585241289274
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Studies have reported an association between socioeconomic status and disability progression in multiple sclerosis (MS), but findings using the pre-MS individual socioeconomic status are missing.Objective: The objective was to investigate the association between education level and disability progression.Methods: All Observatoire Fran & ccedil;ais de la Scl & eacute;rose en Plaques (OFSEP) patients with MS clinical onset over 1960-2014, and aged >= 25 years at MS onset were included. Education level was classified into four categories from low (primary/secondary school) to very high (master/doctoral degree). Time from MS onset to EDSS 4.0 was studied using flexible parametric survival models adjusted for age, period, and center, and stratified by phenotype (relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)) and sex.Results: A total of 11,586 patients were included (women/men ratio = 2.5; age = 36.7 +/- 8.6 years; follow-up duration 16.7 +/- 9.3 years; 86.4% RMS). For women with RMS, the risk of reaching the outcome at 5 years was inversely associated with the education level (Hazard Ratio medium: 0.74 (0.63-0.87), high: 0.51 (0.43-0.62), very high: 0.39 (0.30-0.50) vs low). Results were similar for men. In PPMS, the risk was significantly different between the extreme groups (very high vs low) for women (0.45 (0.28-0.75)) and men (0.54 (0.32-0.91)), but no gradient was evident.Conclusion: Our study showed a strong association between education level and disability progression, regardless of sex and phenotype.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [1] Impact of education level on multiple sclerosis disability progression in France
    Lefort, M.
    Dejardin, O.
    Calocer, F.
    Defer, G.
    Leray, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 113 - 114
  • [2] The Association between Serum Glucose Level and Disability Progression in Multiple Sclerosis
    Richeh, Wael
    Gutierrez, Amparo
    Lovera, Jesus
    NEUROLOGY, 2013, 80
  • [3] Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France
    Lefort, Mathilde
    Dejardin, Olivier
    Berger, Eric
    Camdessanche, Jean-Philippe
    Ciron, Jonathan
    Clavelou, Pierre
    De Seze, Jerome
    Debouverie, Marc
    Heinzlef, Olivier
    Labauge, Pierre
    Laplaud, David Axel
    Michel, Laure
    Lebrun-Frenay, Christine
    Moreau, Thibault
    Pelletier, Jean
    Ruet, Aurelie
    Thouvenot, Eric
    Vukusic, Sandra
    Zephir, Helene
    Defer, Gilles
    Leray, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 69 - 80
  • [4] Association between psychiatric comorbidity and disability progression of multiple sclerosis
    Mckay, K. A.
    Tremlett, H.
    Fisk, J. D.
    Zhang, T.
    Kastrukoff, L.
    Marrie, R. A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 25 - 25
  • [5] Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis
    Merlo, Daniel
    Stankovich, Jim
    Bai, Claire
    Kalincik, Tomas
    Zhu, Chao
    Gresle, Melissa
    Lechner-Scott, Jeannette
    Kilpatrick, Trevor
    Barnett, Michael
    Taylor, Bruce
    Darby, David
    Butzkueven, Helmut
    Van der Walt, Anneke
    NEUROLOGY, 2021, 97 (20) : E2020 - E2031
  • [6] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [7] Serum NSE level and disability progression in multiple sclerosis
    Koch, Marcus W.
    George, Suzanne
    Wall, Winona
    Yong, V. Wee
    Metz, Luanne M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 350 (1-2) : 46 - 50
  • [8] Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 247 - 256
  • [9] Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression
    Zhang, Tingting
    Kingwell, Elaine
    De Jong, Hilda J. I.
    Zhu, Feng
    Zhao, Yinshan
    Carruthers, Robert
    Petkau, John
    Gustafson, Paul
    Oger, Joel
    Tremlett, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (10) : 1150 - 1159
  • [10] Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational
    Shirani, A.
    Zhao, Y.
    Karim, M. E.
    Petkau, J.
    Gustafson, P.
    Evans, C.
    Kingwell, E.
    van der Kop, M. L.
    Oger, J.
    Tremlett, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 835 - 844